Dr. Petr Kavan, Dr
Claim this profileJewish General Hospital
Area of expertise
Pancreatic Cancer
Petr Kavan, Dr has run 4 trials for Pancreatic Cancer. Some of their research focus areas include:
Mixed-Cell Lymphoma
Petr Kavan, Dr has run 2 trials for Mixed-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Jewish General Hospital
The Jewish General Hospital
Clinical Trials Petr Kavan, Dr is currently running
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting
2 awards
Phase 3
12 criteria
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting
2 awards
Phase 3
More about Petr Kavan, Dr
Clinical Trial Related
3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Petr Kavan, Dr has experience with
- Tucatinib
- Oxaliplatin
- Fluorouracil
- Leucovorin
- Vemurafenib Plus Cobimetinib
- Trastuzumab Plus Pertuzumab
Breakdown of trials Petr Kavan, Dr has run
Pancreatic Cancer
Mixed-Cell Lymphoma
Non-Hodgkin's Lymphoma
Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Petr Kavan, Dr specialize in?
Petr Kavan, Dr focuses on Pancreatic Cancer and Mixed-Cell Lymphoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are metastatic.
Is Petr Kavan, Dr currently recruiting for clinical trials?
Yes, Petr Kavan, Dr is currently recruiting for 4 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Petr Kavan, Dr has studied deeply?
Yes, Petr Kavan, Dr has studied treatments such as Tucatinib, Oxaliplatin, Fluorouracil.
What is the best way to schedule an appointment with Petr Kavan, Dr?
Apply for one of the trials that Petr Kavan, Dr is conducting.
What is the office address of Petr Kavan, Dr?
The office of Petr Kavan, Dr is located at: Jewish General Hospital, Montréal, Quebec H3T 1E2 Canada. This is the address for their practice at the Jewish General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.